Skip to main content

Sonoma Pharmaceuticals Inc

For the period ended Aug 14, 2024. Filed Jul 1, 2024.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Aug 14, 2024 · Filed Jul 1, 2024

SNOA$1.11+3.7%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

Appendix A – Proxy Card

Appendix A

Proxy Card

Proposals — The Board of Directors recommend a vote FOR all the nominees listed, FOR Proposals X – X and for every X YEARS on Proposal X. 01 - Philippe Weigerstorfer For Withhold For Withhold 1 U P X 02 - Amy Trombly For Against Abstain Using a black ink pen, mark your votes with an X as shown in this example. Please do not write outside the designated areas. 040OSC + + Proposals — The Board of Directors recommend a vote FOR all the nominees listed and FOR Proposals 2 - 8. A 1. Election of Directors: Please sign exactly as name(s) appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please give full title. Date (mm/dd/yyyy) — Please print date below. Signature 1 — Please keep signature within the box. Signature 2 — Please keep signature within the box. Authorized Signatures — This section must be completed for your vote to count. Please date and sign below. B T IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. T 2024 Annual Meeting Proxy Card 1234 5678 9012 345 4. To approve an amendment to our Restated Certificate of Incorporation, as amended, increasing the number of authorized shares of common stock, $0.0001 par value per share, from 24,000,000 to 50,000,000 6. To approve an amendment to our Restated Certificate of Incorporation, as amended, and authorize the Board of Directors, if in their judgment it is necessary, to effect a reverse stock split of our outstanding common stock at a whole number ratio in the range of 1 - for - 10 to 1 - for - 20 8 . To authorize the adjournment of the meeting to permit further solicitation of proxies, if necessary or appropriate, if sufficient votes are not represented at the meeting to approve any of the foregoing proposals 2. To approve, on an advisory basis, the compensation of our Named Executive Officers for the year ended March 31, 2024 3. To authorize the reincorporation of the Company from the State of Delaware to the State of Nevada 5. To approve the Sonoma Pharmaceuticals, Inc. 2024 Equity Incentive Plan 7. To ratify the appointment of Frazier & Deeter, LLC as our independent auditors for the fiscal year ending March 31, 2025 For Against Abstain MMMMMMMMM 6 2 0 0 1 6 MR A SAMPLE (THIS AREA IS SET UP TO ACCOMMODATE 140 CHARACTERS) MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND C 1234567890 J N T MMMMMMMMMMMM MMMMMMMMMMMMMM MMMMMM If no electronic voting, delete QR code and control # Δ ≈ 000001 MR A SAMPLE DESIGNATION (IF ANY) ADD 1 ADD 2 ADD 3 ADD 4 ADD 5 ADD 6 ENDORSEMENT_LINE SACKPACK C123456789 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext Online Go to http://www.envisionreports.com/SNOA or scan the QR code — login details are located in the shaded bar below. Phone Call toll free 1 - 800 - 652 - VOTE (8683) within the USA, US territories and Canada Save paper, time and money! Sign up for electronic delivery at http://www.envisionreports.com/SNOA Your vote matters – here’s how to vote! You may vote online or by phone instead of mailing this card. Votes submitted electronically must be received by 1:00 am, MDT, on August 14, 2024.

Small steps make an impact. Help the environment by consenting to receive electronic delivery, sign up at http://www.envisionreports.com/SNOA Notice of 2024 Annual Meeting of Shareholders Proxy Solicited by Board of Directors for Annual Meeting — August 14, 2024 Amy Trombly, with the power of substitution, is hereby authorized to represent and vote the shares of the undersigned, with all the powers which the undersigned would possess if personally present, at the Annual Meeting of Shareholders of Sonoma Pharmaceuticals, Inc . to be held on August 14 , 2024 or at any postponement or adjournment thereof . Shares represented by this proxy will be voted by the stockholder . If no such directions are indicated, the Proxies will have authority to vote FOR the election of the Board of Directors and FOR items 2 through 8 . In their discretion, the Proxies are authorized to vote upon such other business as may properly come before the meeting . (Items to be voted appear on reverse side) Sonoma Pharmaceuticals, Inc. T IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. T Change of Address — Please print new address below. Comments — Please print your comments below. Non - Voting Items C + + 2024 Annual Meeting Admission Ticket 2024 Annual Meeting of Sonoma Pharmaceuticals, Inc. Shareholders Wednesday, August 14, 2024, 2:00 P.M. local time Offices of Sonoma Pharmaceuticals, Inc. 5445 Conestoga Court, Unit 150, Boulder, CO 80301 Upon arrival, please present this admission ticket and photo identification at the registration desk.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.